Cancer Playbook, Powered by Whole Health Oncology Institute, Launches the Largest Meta-Analysis to Date on Medical Cannabis and Cancer Symptoms

A groundbreaking meta-analysis by the Whole Health Oncology Institute Our Publicationsreviewed over 10,000 studies and found that 74% showed marijuana helps improve cancer outcomes—from reducing pain, nausea, and appetite loss to even triggering cancer cell death. It’s the strongest scientific confirmation yet that this plant isn’t just palliative; it can actively fight disease.

A meta-analysis of over 10,000 studies found that over 70% of them support the use of medical cannabis in cancer treatment1 2 3. The review, led by Whole Health Oncology Institute, found that cannabis not only helps manage cancer symptoms but may also slow disease progression 1 3.

Over 70% Of Studies Back Medical Cannabis In Cancer Treatment, Meta-Analysis Finds

By Dario Sabaghi,

Dario Sabaghi covers the cannabis industry with a focus on Europe.

A sweeping meta-analysis of over 10,000 studies has found that more than 70% support the use of medical cannabis in cancer treatment, reinforcing growing scientific consensus around its therapeutic potential for managing symptoms and possibly even slowing disease progression.

The study, published in Frontiers in Oncology last week, is a comprehensive meta-analysis that evaluates the therapeutic potential and safety of medical cannabis in the context of cancer treatment.

The authors from Whole Health Oncology Institute and Chopra Foundation tried to understand a group of studies that had mixed or opposing results.

To do this, they used two different approaches. One approach was traditional statistical analysis, which involves numbers and calculations to find patterns. The other approach was sentiment analysis, which uses machine learning to analyze the overall tone or sentiment in the studies.

By combining both methods, the authors were able to get a more accurate and clear understanding of the research on the use of medical cannabis in cancer treatment.

Clinical trials are studying a medicine made from an extract of Cannabis that contains specific amounts of cannabinoids. This medicine is sprayed under the tongue.

Consensus On Cannabis Use In Cancer Treatment

The use of medical cannabis in cancer treatment received strong backing, with 71.4% of studies showing clear support. Positive sentiment was 31.38 times more prevalent than negative sentiment, and in health-related measures, the supportive sentiment was 46.98 times stronger than the opposition.

“These findings revealed a significant trend suggesting support of cannabis’ therapeutic potential, particularly in managing cancer-related symptoms and possibly exerting direct anticarcinogenic effects. Across all categories examined—health metrics, cancer treatments, and cancer dynamics—there is a consistent consensus that supports the potential of medical cannabis,” the study reads.

As 39 U.S. states have legalized cannabis for medical use, and many other countries allow its use for various medical conditions, interest in its potential role in cancer treatment is growing.

In this context, the study aimed to determine whether there is a scientific consensus on the use of medical cannabis for cancer patients, including both palliative care and its potential as an anticancer treatment.

Over the years, several studies have suggested that cannabis could help ease chemotherapy side effects such as pain, nausea, and loss of appetite. It may also play a role in slowing the growth of cancer cells.

However, because cannabis remains illegal at the federal level under Schedule I of the Controlled Substances Act, conducting high-quality research on its use in cancer care remains challenging. This has led to a fragmented body of evidence, with varying study designs, cannabinoid compositions, and patient populations.

Medical Cannabis Use In Chemotherapy

The researchers reviewed over 10,000 peer-reviewed studies, totaling 39,767 data points. They used sentiment analysis, a machine learning technique, to label the research findings as “supported,” “not supported,” or “unclear” about cannabis use.

Medical cannabis was consistently supported for managing pain, nausea, and appetite loss during chemotherapy. The evidence for pain relief was particularly strong, showing clear positive correlations and little negative sentiment. Nausea and appetite loss showed slightly weaker support, with some variation depending on the cannabis formulation used. Many studies emphasized cannabis’ role in alleviating chemotherapy side effects.

While some disagreements remain, most research supports using cannabis alongside standard cancer treatments. Sentiment for cannabis in chemotherapy contexts was 191.75% more likely to be positive than negative.

“This substantial difference suggests a solid consensus in favor of using medical cannabis as an adjunct to chemotherapy, highlighting its potential therapeutic role in enhancing the effectiveness or mitigating the side effects of chemotherapy,” the study reads.

One of the most promising findings is that cannabis might help inhibit tumor growth, encourage apoptosis (cell death) in cancer cells, and reduce inflammation. The topic of its anticancer effects showed no significant opposition in the literature, indicating a growing consensus, although clinical trials are still limited.

Personalized Cannabis Therapy For Cancer Treatment

Researchers acknowledged that cannabis is not a uniform substance, as its effects can change depending on the THC-to-CBD ratio, the presence of minor cannabinoids, and the type of formulation, such as full-spectrum and isolated. Different cancers, like breast, glioblastoma, and melanoma, also respond differently to cannabis treatments, highlighting the need for personalized cannabinoid therapies and more research into how cannabis affects specific cancer types.

“Future clinical trials should move beyond generic CBD-based studies to explore the full therapeutic potential of comprehensive cannabinoid formulations, incorporating THC and other cannabis-derived compounds where legally and ethically feasible,” they said.

The study, however, has some limitations. There is a lack of clinical trials, and much of the evidence comes from preclinical and observational studies. Sentiment analysis tools may also misclassify technical or neutral language.

Still, even with these limitations, the findings of this meta-analysis strongly support the use of medical cannabis in treatment.

Challenges remain, especially when it comes to standardizing formulations and focusing on specific cancer types, but the results suggest it may be time to rethink the legal and clinical status of cannabis in medicine.

Therapeutic Effects of Cannabis and Cannabinoids – The Health Effects of Cannabis and Cannabinoids – NCBI Bookshelf

What are the health benefits and risks of cannabis?

Led by Cancer Playbook, powered by Whole Health Oncology Institute (WHOI), this systematic research review aggregated data from over 10,000 peer-reviewed studies—a scale never before achieved in this field, and over ten times the number included in the next-largest review.

Despite the decades-long lack of consensus regarding the efficiency of cannabis in treating cancer symptoms, the meta-analysis showed that for every one study that showed cannabis was ineffective, there were three that showed it worked. That 3:1 ratio—especially in a field as rigorous as biomedical research—isn’t just unusual, it’s extraordinary. The level of consensus found here rivals or exceeds that for many FDA-approved medications.

“We expected controversy. What we found was overwhelming scientific consensus,” said Ryan Castle, Head of Research at Whole Health Oncology Institute. “This is one of the clearest, most dramatic validations of medical cannabis in cancer care that the scientific community has ever seen.”

Because cannabis remains federally illegal, research efforts have often been blocked from receiving grants. This has left a vacuum in peer-reviewed, large-scale data—which Cancer Playbook has now filled with this independently funded meta-analysis. In the recent DEA hearings regarding the rescheduling of cannabis, Cancer Playbook’s data was an important part of the official scientific evidence presented to the DEA.

Key findings from the meta-analysis:

Cannabis reduced cancer cell proliferation
It inhibited metastasis, limiting cancer spread
It increased apoptosis (natural cancer cell death)
It has a profound anti-inflammatory effect, a critical factor since inflammation is linked to over 80% of the world’s most debilitating chronic diseases

Though this study is based on peer-reviewed work, Cancer Playbook makes the case that research can only paint part of the picture. By building on a dual foundation of research and patient experience, Cancer Playbook is redefining cancer support. The platform blends cutting-edge research with Patient Reported Outcomes (PROs), crowdsourcing real-world data from people living with cancer.

“The science matters. But so does the patient,” said Castle. “We are trying to support whole human beings, and that starts by listening to them.”

The significance of PROs is growing rapidly in modern medicine, as traditional clinical trials measure biological responses but often overlook what the patient is actually going through. PROs fill that gap, turning subjective experiences—like pain, fatigue, or emotional distress—into scientifically valid data. This is especially critical when looking at treatments like cannabis, where personal experience plays such a pivotal role in perceived and measurable benefit.

“Too often, people turn to cannabis as a last resort. We believe it should be part of the conversation from day one,” said Jim Gerencser, Founder of Cancer Playbook. “Refer to us at Cancer Playbook first as you weigh conventional treatment options. Don’t wait until traditional options have been exhausted. Whether or not you choose cannabis, we offer a fuller picture of what’s possible—one rooted in evidence, experience, and a belief that patients should be at the center of their own care.

Whole Health Oncology Institute reviewed over 10,000 studies and found that 74% showed marijuana helps improve cancer outcomes – Search

This platform was built for patients, by patients, backed by the best data in the world.”